Northstar Asset Management Inc. Sells 7,271 Shares of Danaher Corporation $DHR

Northstar Asset Management Inc. decreased its holdings in Danaher Corporation (NYSE:DHRFree Report) by 59.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,999 shares of the conglomerate’s stock after selling 7,271 shares during the quarter. Northstar Asset Management Inc.’s holdings in Danaher were worth $952,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. BlackRock Inc. bought a new position in Danaher during the second quarter valued at approximately $10,492,520,000. State Street Corp grew its position in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares during the period. Capital International Investors grew its position in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares during the period. Wellington Management Group LLP raised its stake in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after buying an additional 1,542,310 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.3%

Shares of NYSE:DHR opened at $216.41 on Friday. The stock has a 50 day moving average of $199.46 and a 200 day moving average of $192.52. The company has a market cap of $152.13 billion, a PE ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter last year, the business earned $0.77 EPS. The firm’s revenue was up 5.5% compared to the same quarter last year. As a group, equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

DHR has been the topic of a number of research reports. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Wells Fargo & Company lowered their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Evercore reissued an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Citigroup initiated coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Finally, Royal Bank Of Canada upped their target price on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Get Our Latest Stock Analysis on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.